華爾街頂級分析師對這些頂尖公司改變了他們的展望。有關所有分析師評級變動的完整視圖，包括上調、下調和首次評級，請查看我們的 分析師評級頁面。
<ul>
<li>BTIG 分析師 Julian Harrison 將 Outlook Therapeutics Inc (NASDAQ: OTLK) 的評級從買入下調至中性。Outlook Therapeutics 的股票週五收於 $0.23。查看其他分析師對該股票的看法。</li>
<li>摩根士丹利分析師 Shane Brett 將 Applied Materials Inc (NASDAQ: AMAT) 的評級從超配下調至等權，並宣佈目標價為 $502。Applied Materials 的股票週五收於 $436.62。查看其他分析師對該股票的看法。</li>
<li>DA Davidson 分析師 Gil Luria 將 CoreWeave Inc (NASDAQ: CRWV) 的評級從買入下調至中性，並將目標價從 $175 下調至 $100。CoreWeave 的股票週五收於 $107.30。查看其他分析師對該股票的看法。</li>
<li>Leerink Partners 分析師 Andrew Berens 將 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) 的評級從跑贏大盤下調至市場表現，並將目標價從 $792 大幅下調至 $641。Regeneron Pharmaceuticals 的股票週五收於 $698.25。查看其他分析師對該股票的看法。</li>
<li>DA Davidson 分析師 Clark Wright 將 LiveRamp Holdings (NYSE: RAMP) 的評級從買入下調至中性，並將目標價從 $35 上調至 $38.5。LiveRamp 的股票週五收於 $29.66。查看其他分析師對該股票的看法。</li>
</ul>
考慮購買 CRWV 股票嗎？以下是分析師的看法：

圖片來源於 Shutterstock

再生元制藥

RAMP

CRWV

OTLK

動態半導體 ETF - Invesco

半導體 ETF - VanEck Vectors

標普半導體 ETF - SPDR

華爾街分析師已將多隻股票評級下調，包括應用材料公司（Applied Materials, AMAT），其評級從 “增持” 下調至 “持平”，目標價為 502 美元。其他下調的股票包括 Outlook Therapeutics（OTLK）、CoreWeave（CRWV）、再生元製藥（Regeneron Pharmaceuticals, REGN）和 LiveRamp Holdings（RAMP）。欲查看分析師評級變動的完整列表，請訪問 Benzinga 的分析師評級頁面

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
<div class="lb-trans">華爾街頂級分析師對這些頂尖公司改變了他們的展望。有關所有分析師評級變動的完整視圖，包括上調、下調和首次評級，請查看我們的 分析師評級頁面。
</div><ul>
<li>BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc (NASDAQ: OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $0.23 on Friday. See how other analysts view this stock.</li>
<li>Morgan Stanley analyst Shane Brett downgraded Applied Materials Inc (NASDAQ: AMAT) from Overweight to Equal-Weight and announced a $502 price target. Applied Materials shares closed at $436.62 on Friday. See how other analysts view this stock.</li>
<li>DA Davidson analyst Gil Luria downgraded CoreWeave Inc (NASDAQ: CRWV) from Buy to Neutral and cut the price target from $175 to $100. CoreWeave shares closed at $107.30 on Friday. See how other analysts view this stock.</li>
<li>Leerink Partners analyst Andrew Berens downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from Outperform to Market Perform and slashed the price target from $792 to $641. Regeneron Pharmaceuticals shares closed at $698.25 on Friday. See how other analysts view this stock.</li>
<li>DA Davidson analyst Clark Wright downgraded LiveRamp Holdings (NYSE: RAMP) from Buy to Neutral and raised the price target from $35 to $38.5. LiveRamp shares closed at $29.66 on Friday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>BTIG 分析師 Julian Harrison 將 Outlook Therapeutics Inc (NASDAQ: OTLK) 的評級從買入下調至中性。Outlook Therapeutics 的股票週五收於 $0.23。查看其他分析師對該股票的看法。</li>
<li>摩根士丹利分析師 Shane Brett 將 Applied Materials Inc (NASDAQ: AMAT) 的評級從超配下調至等權，並宣佈目標價為 $502。Applied Materials 的股票週五收於 $436.62。查看其他分析師對該股票的看法。</li>
<li>DA Davidson 分析師 Gil Luria 將 CoreWeave Inc (NASDAQ: CRWV) 的評級從買入下調至中性，並將目標價從 $175 下調至 $100。CoreWeave 的股票週五收於 $107.30。查看其他分析師對該股票的看法。</li>
<li>Leerink Partners 分析師 Andrew Berens 將 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) 的評級從跑贏大盤下調至市場表現，並將目標價從 $792 大幅下調至 $641。Regeneron Pharmaceuticals 的股票週五收於 $698.25。查看其他分析師對該股票的看法。</li>
<li>DA Davidson 分析師 Clark Wright 將 LiveRamp Holdings (NYSE: RAMP) 的評級從買入下調至中性，並將目標價從 $35 上調至 $38.5。LiveRamp 的股票週五收於 $29.66。查看其他分析師對該股票的看法。</li>
</ul>
</div>Considering buying CRWV stock? Here’s what analysts think:
<div class="lb-trans">考慮購買 CRWV 股票嗎？以下是分析師的看法：
</div>
<div class="lb-trans">
</div>Photo via Shutterstock
<div class="lb-trans">圖片來源於 Shutterstock
</div>

This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

benzinga_article

LiveRamp

Coreweave

Outlook Therapeutics

應用材料

這位應用材料公司的分析師不再持樂觀態度；以下是週一的五大降級